Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 87301-87350 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05242315
Extended-Release Tacrolimus Following Liver Transplantation
PHASE4Recruiting
94 participants
Started: May 15, 2022 · Completed: Feb 15, 2034
5 conditions1 sponsor1 location
NCT05420766
Impact of Sleep Duration on Immune Balance in Urban Children With Asthma
NARecruiting
204 participants
Started: May 15, 2022 · Completed: Jul 31, 2026
3 conditions3 sponsors1 location
NCT05299164
GVM±R in Patients With Relapsed or Refractory Aggressive NHL
PHASE1Active, not recruiting
18 participants
Started: May 15, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05599568
Repeated Bout Effect i Neuromuscular Diseases
NARecruiting
50 participants
Started: May 15, 2022 · Completed: May 30, 2026
1 condition1 sponsor1 location
NCT05412693
Functional Orthosis Versus Cast Immobilization for Partially Unstable Weber B Ankle Fractures
NAActive, not recruiting
110 participants
Started: May 15, 2022 · Completed: Dec 31, 2025
1 condition3 sponsors3 locations
NCT06731842
Molecular PET Imaging and Plasma Biomarkers in Alzheimer´s Disease and Other Neurodegenerative Diseases
NAEnrolling by invitation
100 participants
Started: May 15, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05167903
The Effect of Time-restricted Eating Combined With Exercise Training on Body Composition and Cardiometabolic Health
NARecruiting
50 participants
Started: May 15, 2022 · Completed: Dec 1, 2024
1 condition1 sponsor1 location
NCT05312203
Alleviating Stress by Mobile Application' for Depression
NARecruiting
42 participants
Started: May 15, 2022 · Completed: Dec 31, 2023
1 condition2 sponsors1 location
NCT05863741
Clinical Utility and Gait Analysis of NextAR System AUS
N/ARecruiting
100 participants
Started: May 15, 2022 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT05359601
Infusion Set Replacement Intervals for Critically Ill Patients
NARecruiting
1,240 participants
Started: May 15, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT06021509
Clinical Study of NovoClasp for Treating Moderate to Severe and Severe Degenerative Mitral Regurgitation
NAActive, not recruiting
102 participants
Started: May 15, 2022 · Completed: Jun 25, 2028
1 condition1 sponsor1 location
NCT05581069
Improving Outcomes in Autism: Community Implementation of Stepped Transition in Education Program
NARecruiting
25 participants
Started: May 15, 2022 · Completed: Aug 1, 2024
1 condition1 sponsor1 location
NCT05173233
Confirmatory Clinical Study of Treating Tricuspid Regurgitation With K-Clip TM Transcatheter Annuloplasty System
NANot yet recruiting
67 participants
Started: May 15, 2022 · Completed: May 15, 2027
1 condition1 sponsor0 locations
NCT05384951
HMB Cerebral Palsy Pilot Study
NAActive, not recruiting
7 participants
Started: May 15, 2022 · Completed: May 31, 2024
1 condition3 sponsors1 location
NCT05413109
COMPression of Left Main coRonary artEry in patientS With Pulmonary Arterial Hypertension aSymptomatIc fOr aNgina
NARecruiting
150 participants
Started: May 15, 2022 · Completed: May 15, 2026
1 condition1 sponsor1 location
NCT05378971
Clinical Research of Pomalidomide Maintenance Therapy for Primary Multiple Myeloma
NARecruiting
15 participants
Started: May 15, 2022 · Completed: May 30, 2025
1 condition2 sponsors1 location
NCT05320549
Effect of a Community Exercise Programme on Stroke Patients
NARecruiting
150 participants
Started: May 15, 2022 · Completed: May 31, 2024
1 condition4 sponsors1 location
NCT04416191
Immune Cells During Disuse and Recovery
NARecruiting
45 participants
Started: May 15, 2022 · Completed: Apr 30, 2028
1 condition1 sponsor1 location
NCT05379569
Comparative Study of BFC and BuCy Conditioning Regimen for Allo-PBSCT in Acute B-cell ALL
PHASE4Recruiting
142 participants
Started: May 15, 2022 · Completed: Dec 30, 2025
2 conditions1 sponsor1 location
NCT05304481
Efficacy and Safety of Activated T Lymphocytes (ATL) in Hepatocellular Carcinoma
PHASE2Recruiting
95 participants
Started: May 14, 2022 · Completed: Jun 30, 2027
1 condition2 sponsors13 locations
NCT05371353
Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine
N/ARecruiting
600 participants
Started: May 14, 2022 · Completed: May 31, 2027
7 conditions1 sponsor2 locations
NCT06393699
Restoration of Non-carious Cervical Lesions With Different Resin Composites and Universal Adhesive
NARecruiting
52 participants
Started: May 14, 2022 · Completed: Dec 30, 2026
1 condition1 sponsor1 location
NCT06366061
A COMPARISON OF LEFT VENTRICULAR FUNCTION IN THE APICAL 4 CHAMBER AND SUBCOSTAL 4 CHAMBER TTE VIEWS IN THE PERIOPERATIVE SETTING
N/ARecruiting
100 participants
Started: May 14, 2022 · Completed: Dec 1, 2024
1 condition1 sponsor1 location
NCT05493514
Clinical and Instrumental Treatment's Predictors in Subjects With Neurological Diseases Using G-EO Robotic System
N/ARecruiting
260 participants
Started: May 13, 2022 · Completed: Apr 1, 2027
4 conditions1 sponsor1 location
NCT05358704
Preoperative ChemoRadiation And FOLFOXIRI for Rectal Cancer (CRAFTER) for Rectal Cancer
PHASE2Recruiting
38 participants
Started: May 13, 2022 · Completed: Jan 30, 2026
1 condition1 sponsor5 locations
NCT05199311
Carfilzomib, Iberdomide (CC-220) and Dexamethasone (KID) in Transplant Eligible Multiple Myeloma
PHASE1/PHASE2Recruiting
66 participants
Started: May 13, 2022 · Completed: Nov 30, 2025
1 condition1 sponsor2 locations
NCT04651439
Severe Bullous Drug Eruption and Filgrastim
PHASE2/PHASE3Recruiting
42 participants
Started: May 13, 2022 · Completed: May 13, 2026
2 conditions1 sponsor3 locations
NCT05498064
A Real World Study of Ensartinib in Advanced ALK-positive NSCLC
N/ARecruiting
490 participants
Started: May 13, 2022 · Completed: Dec 1, 2028
3 conditions2 sponsors1 location
NCT05639153
A Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of DR30303 in Patients With Advanced Solid Tumors
PHASE1Recruiting
94 participants
Started: May 13, 2022 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT06075433
Efficacy and Safety of 1-year Duration of DAPT After GENOSS® DES Implantation in Patients with Coronary Artery Disease According to the Complex Higher-risk Procedure
N/ARecruiting
1,000 participants
Started: May 13, 2022 · Completed: Dec 31, 2027
3 conditions1 sponsor1 location
NCT05177068
Conversion Therapy of Fruquintinib in Combination With Sintilimab and SOX in Unresectable Gastric Cancer
PHASE2Active, not recruiting
42 participants
Started: May 13, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05415631
Augmented Bladder Tumor Detection Using Real Time Based Artificial Intelligence
N/ARecruiting
500 participants
Started: May 13, 2022 · Completed: May 31, 2029
3 conditions1 sponsor1 location
NCT05327959
A.L.P.S. Clavicle Plating System PMCF
NAEnrolling by invitation
98 participants
Started: May 13, 2022 · Completed: Mar 31, 2027
2 conditions1 sponsor5 locations
NCT05206695
Simultaneously Implementing Pathways for Improving Asthma, Pneumonia, and Bronchiolitis Care for Hospitalized Children
NAActive, not recruiting
3,840 participants
Started: May 13, 2022 · Completed: Jun 30, 2026
3 conditions3 sponsors1 location
NCT05335473
Iribrine Plus Tucidinostat in the Treatment of HR+/HER2 Advanced Breast Cancer After CDK4/6 Inhibitor Failure
PHASE1/PHASE2Recruiting
87 participants
Started: May 13, 2022 · Completed: Nov 1, 2025
1 condition1 sponsor1 location
NCT06209281
A Phase III Clinical Study of the Efficacy and Safety of Two Low-concentration Atropine Sulfate Eye Drops
PHASE3Active, not recruiting
526 participants
Started: May 13, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05338307
Preliminary Investigation of β-hydroxybutyrate Supplementation in Colorectal Cancer Prevention
NAActive, not recruiting
20 participants
Started: May 13, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05369299
Clinical Outcome of Two-piece Zirconia Implants in Immediate Implant Placement
NAActive, not recruiting
33 participants
Started: May 13, 2022 · Completed: Nov 1, 2025
1 condition1 sponsor1 location
NCT05235854
Six-month Performance of Meniscal Wall Infiltration Under Ultrasound to Treat Stable Degenerative Meniscal Injuries.
PHASE1Recruiting
70 participants
Started: May 12, 2022 · Completed: Nov 1, 2025
1 condition1 sponsor1 location
NCT05039619
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
PHASE2Recruiting
40 participants
Started: May 12, 2022 · Completed: Sep 28, 2029
1 condition2 sponsors42 locations
NCT05368259
The AUDACITY Study (AllUrion Device in Adults With Clinical ObesITY)
NAActive, not recruiting
1,000 participants
Started: May 12, 2022 · Completed: Mar 1, 2025
1 condition1 sponsor17 locations
NCT05267535
Piromelatine 20 mg in Participants With Mild Dementia Due to Alzheimer's Disease
PHASE2/PHASE3Active, not recruiting
225 participants
Started: May 12, 2022 · Completed: Jun 30, 2025
1 condition2 sponsors37 locations
NCT04950309
Characterization of an Optically Pumped Magnetometer (OPM) Magnetoencephalography (MEG) Array
NARecruiting
75 participants
Started: May 12, 2022 · Completed: Aug 1, 2026
1 condition1 sponsor1 location
NCT05323240
Health Effects of Repeated Exposure to Low Levels of Concentrated Ambient Particles in Healthy Young Volunteers
NARecruiting
20 participants
Started: May 12, 2022 · Completed: Dec 20, 2025
1 condition1 sponsor1 location
NCT05119036
Adjuvant Treatment Deintensification After Transoral Surgery for Human Papillomavirus-Positive Squamous Cell Carcinoma
NAActive, not recruiting
83 participants
Started: May 12, 2022 · Completed: Apr 30, 2026
2 conditions1 sponsor2 locations
NCT05405712
Mobile Peer Support for OUD Recovery
NARecruiting
1,300 participants
Started: May 12, 2022 · Completed: Mar 31, 2027
1 condition4 sponsors2 locations
NCT04754321
Combining Immunotherapy Salvage Surgery & IORT Tx Persistent/Recurrent Head & Neck Cancer
PHASE1Recruiting
45 participants
Started: May 12, 2022 · Completed: Dec 31, 2025
6 conditions1 sponsor1 location
NCT05285904
Kesimpta® (Ofatumumab) in Swiss Multiple Sclerosis Patients - an Observational Study
N/AActive, not recruiting
107 participants
Started: May 12, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor13 locations
NCT05357482
Addition of JSP191 (C-kit Antibody) to Nonmyeloablative Hematopoietic Cell Transplantation for Sickle Cell Disease and Beta-Thalassemia
PHASE1/PHASE2Active, not recruiting
40 participants
Started: May 12, 2022 · Completed: Jan 31, 2027
2 conditions1 sponsor1 location
NCT05023044
Nonalcoholic Fatty Liver Disease in HIV Database
N/ARecruiting
400 participants
Started: May 12, 2022 · Completed: Jan 31, 2026
3 conditions2 sponsors8 locations